R. Huber (Munich, Germany), I. Opitz (Zurich, Switzerland)
Influence mesenchymal stem cells on aneuploidy of the tumor cells of Lewis lung carcinoma
T. Nikolaienko (Kyiv, Ukraine), L. Garmanchuk (Kyiv, Ukraine), O. Dzhus (Kyiv, Ukraine), L. Kladnytska (Kyiv, Ukraine)
|  |
Targeting Tryptophan metabolism pathway as a therapeutic strategy for non-small cell lung cancer
E. Jin (Hangzhou, China), Y. Li (Hangzhou, China), X. Chen (durham, United States of America), S. Ma (Hangzhou, China)
| |
Effect of 14-3-3 protein induction on oncogenic potential of BEAS-2B bronchial epithelial cells
R. Hamon (Adelaide, Australia), C. Coolen (Adelaide, Australia), P. Reynolds (Adelaide, Australia), S. Pitson (Adelaide, Australia), J. Woodcock (Adelaide, Australia)
| |
Macrophage immunophenotypic and monocyte activation markers in the immune response in lung cancer
I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), M. Polubiec-Kownacka (Warsaw, Poland), P. Rzepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland)
|  |
Difference of Copy number variation in the blood between patients with lung cancer and control
J. Heo (Chuncheon, Republic of Korea), Y. Heo (Chuncheon, Republic of Korea), Y. Hong (Chuncheon, Republic of Korea), S. Han (Chuncheon, Republic of Korea), H. Cheong (Seoul, Republic of Korea), W. Kim (Chuncheon, Republic of Korea)
| |
Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker
Y. Zhang (Tianjin, China), Q. Chen (Tianjin, China), J. Chao (Tianjin, China), J. Zhang (Tianjin, China), L. Dong (Tianjin, China)
| |
Prognostic Significance of Hematologic Biomarkers in Small Cell Lung Cancer: a Meta Analysis and Systematic Review
C. BARBON (Manila, Philippines), R. Velasco (Manila, Philippines), D. Sacdalan (Manila, Philippines), N. Maghuyop (Manila, Philippines)
| |
Identification of genes with diagnostic and prognostic value in lung cancer.
M. Arroyo Varela (Málaga, Spain), E. Salcedo Lobera (Málaga, Spain), R. Larrosa Jiménez (Málaga, Spain), R. Bautista Moreno (Málaga, Spain), J. De La Cruz Ríos (Málaga, Spain), M. Claros Díaz (Málaga, Spain)
| |
Changes in the pulmonary microbiome associated with lung cancer
J. Vengoechea (Zaragoza, Spain), M. Ponce-Alonso (Madrid, Spain), A. Figueredo (Zaragoza, Spain), E. Micholé (Zaragoza, Spain), L. Torralba (Zaragoza, Spain), J. Errasti (Zaragoza, Spain), E. Vera (Zaragoza, Spain), A. Rezusta (Zaragoza, Spain), R. Del Campo (Madrid, Spain), S. Bello (Zaragoza, Spain)
| |
Non-classical monocytes potentiates the pathogenesis of malignant pleural effusion via the production of IL-1ß
L. Luo (Changsha, China), X. Li (ChangshaChangsha, China), X. Hu (Changsha, China), P. Deng (Changsha, China), W. Tang (Changsha, China), S. Deng (Changsha, China), C. Hu (Changsha, China), . Feng (Changsha, China)
| |
FGFR1-4 and MET expression analysis and evaluation of reliable reference genes in Sq-NSCLC
J. Moes-Sosnowska (Warsaw, Poland), E. Szczepulska-Wojcik (Warsaw, Poland), A. Rozy (Warsaw, Poland), S. Rudzinski (Warsaw, Poland), R. Langfort (Warsaw, Poland), P. Rudzinski (Warsaw, Poland), T. Orlowski (Warsaw, Poland), J. Chorostowska-Wynimko (Warsaw, Poland)
| |
NRG1 Fusion-Positive Lung Cancers: Clinicopathologic Profile and Treatment Outcomes from a Global Multicenter Registry
M. Duruisseaux (Lyon, France), A. Drilon (New York, United States of America), J. Han (Goyang, Republic of Korea), V. Gounant (Paris, France), J. Shih (Taipei, Taiwan), A. Schram (New York, United States of America), F. Magne (Villefranche-sur-saone, France), I. Monnet (Créteil, France), D. Moro-Sibilot (Grenoble, France), T. Blum (Berlin, Germany), T. Patil (Denver, United States of America), R. Doebele (Denver, United States of America), D. Camidge (Denver, United States of America), L. Muscarella (San Giovanni Rotondo, Italy), S. Liu (Washington, DC, United States of America), J. Cadranel (Paris, France)
| |
Mast cells act as partners in tumour cells metastasis to promote angiogenesis via exosomes
H. Xiao (Shanghai, China)
| |
Effects of ASCL1 expression on tumorigenesis and immune cell infiltration in a syngenic mouse model of lung adenocarcinoma
N. Miyashita (Tokyo, Japan), . Horie (Los Angels, United States of America), Y. Mikami (Tokyo, Japan), H. Urushiyama (Tokyo, Japan), K. Fukuda (Tokyo, Japan), K. Makita (Tokyo, Japan), H. Matsuzaki (Tokyo, Japan), A. Saito (Tokyo, Japan), T. Nagase (Tokyo, Japan)
| |
Lung cancer characteristics in never smokers. Results from the LCRINS study.
A. Casal (Santiago de Compostela, Spain), M. Torres (Vigo, Spain), I. Parente (Orense, Spain), M. Provencio (Madrid, Spain), A. Golpe (Santiago de Compostela, Spain), C. Montero (A Coruña, Spain), I. Vidal (A Coruña, Spain), V. Leiro (Vigo, Spain), C. Martínez (Oviedo, Spain), O. Castro (Lugo, Spain), A. Fernández (Vigo, Spain), L. Valdés (Santiago de Compostela, Spain), A. Ruano (Santiago de Compostela, Spain)
| |
Exosomes form EGFR-mutated adenocarcinoma induce tumour invasion
A. JOUIDA (Dublin, Ireland), E. Crisetti (Dublin, Ireland), C. Mccarthy (Dublin, Ireland), A. Fabre (Dublin, Ireland), K. Mcauley (Dublin, Ireland), A. Kelly (Dublin, Ireland), M. Ocallaghan (Dublin, Ireland), M. Keane (Dublin, Ireland)
| |
A549 cell promotes the proliferation and migration of fibroblast through FXR pathway
H. Jiang (Shanghai, China), F. Wang (Qingdao, China)
| |